发明申请
- 专利标题： Engineered CXCL12 Alpha Locked Dimer Polypeptide
- 专利标题（中）： 工程CXCL12 Alpha锁定二聚体多肽
-
申请号： US12956514申请日： 2010-11-30
-
公开(公告)号： US20110091410A1公开(公告)日： 2011-04-21
- 发明人: Brian F. Volkman , Christopher T. Veldkamp , Francis C. Peterson , Thomas Sakmar , Christoph H. Seibert
- 申请人： Brian F. Volkman , Christopher T. Veldkamp , Francis C. Peterson , Thomas Sakmar , Christoph H. Seibert
- 申请人地址： US WI Milwaukee
- 专利权人： Medical College of Wisconsin Research Foundation
- 当前专利权人： Medical College of Wisconsin Research Foundation
- 当前专利权人地址： US WI Milwaukee
- 主分类号： A61K38/19
- IPC分类号： A61K38/19 ; A61P37/06 ; A61P31/18 ; A61P35/00 ; A61P35/02
摘要：
The present invention provides a novel CXCL12-α2 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.
公开/授权文献
- US08524670B2 Engineered CXCL12 alpha locked dimer polypeptide 公开/授权日：2013-09-03